In the future, these in vivo effects of PP13 need to be further investigated in humans, presumably on placental bed arteries in hysterectomy specimens and also on placental derived in vitro decidual models in order to evaluate the potential therapeutic use of PP13 to prevent preeclampsia, along with many additional considerations. The gene discussed is LGALS13; the disease is preeclampsia.